SCM
EVH icon

Sterling Capital Management’s Evolent Health EVH Stock Holding History

Sterling Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86K Sell
1,634
-1,107
-40% -$4.24K ﹤0.01% 2290
2026
Q1 		$6.25K Sell
2,741
-2,304
-46% -$7.31K ﹤0.01% 2621
2025
Q4 		$20.2K Sell
5,045
-139,363
-97% -$775K ﹤0.01% 2222
2025
Q3 		$1.22M Buy
144,408
+42,115
+41% +$409K 0.02% 571
2025
Q2 		$1.15M Buy
102,293
+2,112
+2% +$19.4K 0.02% 576
2025
Q1 		$949K Sell
100,181
-6,163
-6% -$62.3K 0.01% 631
2024
Q4 		$1.2M Buy
106,344
+28,424
+36% +$500K 0.02% 588
2024
Q3 		$2.2M Buy
+77,920
New +$2.01M 0.03% 361
2019
Q3 		$1.68M Buy
233,151
+48,347
+26% +$347K 0.02% 456
2019
Q2 		$1.47M Buy
184,804
+38,458
+26% +$455K 0.01% 471
2019
Q1 		$1.84M Buy
146,346
+26,721
+22% +$423K 0.02% 415
2018
Q4 		$2.39M Buy
119,625
+7,161
+6% +$166K 0.03% 346
2018
Q3 		$3.19M Hold
112,464
– – 0.03% 318
2018
Q2 		$2.37M Buy
+112,464
New +$2.13M 0.02% 371

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sterling Capital Management's EVH Position: Q2 2026 in Review

Sterling Capital Management reduced its Evolent Health (EVH) stake by 40% in Q2 2026, selling an estimated $4.24K and leaving 1,634 shares worth $8.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Sterling Capital Management first reported a position in EVH in Q2 2018 and has held it in 14 quarters since. The position peaked at $3.19M in Q3 2018. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Sterling Capital Management held 1,634 shares of Evolent Health worth $8.86K as of Q2 2026.
  • Sterling Capital Management sold 1,107 Evolent Health shares in Q2 2026, an estimated $4.24K.
  • Evolent Health made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2290 holding.
  • Sterling Capital Management first reported a position in Evolent Health in Q2 2018 and has held it in 14 quarters since.
  • Sterling Capital Management's Evolent Health position peaked at $3.19M in Q3 2018.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.